These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5643645)

  • 1. The NARD and Dr. Goddard.
    Provost GP
    Am J Hosp Pharm; 1968 Feb; 25(2):59. PubMed ID: 5643645
    [No Abstract]   [Full Text] [Related]  

  • 2. PPIs: community pharmacists' perceptions.
    Kaczmarek ER; Stewart JE; Hutchinson RA
    Contemp Pharm Pract; 1982; 5(3):143-9. PubMed ID: 10256917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 4. Dr. Goddard: firm hand on drug safety.
    Foster JT
    Mod Hosp; 1966 Nov; 107(5):99-100. PubMed ID: 5978522
    [No Abstract]   [Full Text] [Related]  

  • 5. Dr. Goddard and the PMA.
    Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222
    [No Abstract]   [Full Text] [Related]  

  • 6. An interview with Dr. James L. Goddard.
    Callahan B
    Hosp Prog; 1967 Sep; 48(9):62-6. PubMed ID: 6073602
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA's Dr. Kennedy answers 12 questions.
    Kennedy D
    Pharm Times; 1978 Aug; 44(8):44-7. PubMed ID: 10237028
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Dr. Jekyll and Mr. Hyde.
    Feldmann EG
    J Pharm Sci; 1974 Mar; 63(3):1. PubMed ID: 4820358
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists in FDA.
    Welsh JS
    Am Pharm; 1980 Jan; NS20(1):28-32. PubMed ID: 7369115
    [No Abstract]   [Full Text] [Related]  

  • 11. Compounding: if not pharmacists, then who?
    Laven DL
    Am Pharm; 1991 Apr; NS31(4):7. PubMed ID: 2038965
    [No Abstract]   [Full Text] [Related]  

  • 12. Include pharmacists in the loop when it comes to ECP education.
    Contracept Technol Update; 1999 Jun; 20(6):61-4. PubMed ID: 12295212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behind-the-counter status and availability of emergency contraception.
    Gee RE; Shacter HE; Kaufman EJ; Long JA
    Am J Obstet Gynecol; 2008 Nov; 199(5):478.e1-5. PubMed ID: 18554568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US clamp down on web pharmacies.
    Bonetta L
    Nat Med; 2001 Jan; 7(1):6. PubMed ID: 11135588
    [No Abstract]   [Full Text] [Related]  

  • 15. What happens to expired medications? A survey of community medication disposal.
    Kuspis DA; Krenzelok EP
    Vet Hum Toxicol; 1996 Feb; 38(1):48-9. PubMed ID: 8825752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nearly 75% of all active pharmacists now practice in community pharmacies.
    Pharm Times; 1982 Oct; 48(10):34-5. PubMed ID: 10257233
    [No Abstract]   [Full Text] [Related]  

  • 17. The drug recall dilemma.
    Provost GP
    Am J Hosp Pharm; 1966 Oct; 23(10):541. PubMed ID: 5915775
    [No Abstract]   [Full Text] [Related]  

  • 18. Internet pharmacies: cyberspace versus the regulatory state.
    Clevenger T
    J Law Health; 2000-2001; 15(2):165-87. PubMed ID: 12238321
    [No Abstract]   [Full Text] [Related]  

  • 19. NARD--a commitment to the independent community pharmacist.
    D'Angelo SJ
    J Am Pharm Assoc; 1977 Jul; 17(7):443-5. PubMed ID: 881542
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
    Willig SH
    Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.